BioMed Central, acquired in 2008 by Springer, will provide its expertise and technology to help establish the SpringerOpen portfolio. SpringerOpen journals will publish in emerging and interdisciplinary fields and will complement both the established Springer journal portfolios and BioMed Central’s growing list of over 200 life science and biomedicine journal titles. Furthermore, in order to reduce the financial burden faced by individual authors, Springer and BioMed Central are collaborating to extend BioMed Central’s Open Access Membership scheme, offered to institutions, societies, groups, funders and corporations, to include the SpringerOpen titles. More than 300 institutional open access membership arrangements are currently in place.
- Companies:
- Springer
- People:
- Wim van der Stelt